Advertisement
Screener

JASPER THERAPEUTICS, INC. (JSPR) Material Contracts

JASPER THERAPEUTICS, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-07-17: Form 8-K; Exhibit 10.2; Description FORM OF REGISTRATION RIGHTS AGREEMENT, BY AND AMONG JASPER THERAPEUTICS, INC. AND THE INVESTORS SIGNATORY THERETO.
  • 2026-07-17: Form 8-K; Exhibit 10.1; Description FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF JULY 16, 2026, BY AND AMONG JASPER THERAPEUTICS, INC. AND EACH INVESTOR LISTED ON EXHIBIT A THERETO.
  • 2025-02-28: Form 10-K; Exhibit 10.17; Description JASPER THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY..
  • 2024-06-12: Form 8-K; Exhibit 10.6; Description AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED AS OF JUNE 10, 2024, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND EDWIN TUCKER.
FiledFormExhibitDescription
2026-07-178-K10.2FORM OF REGISTRATION RIGHTS AGREEMENT, BY AND AMONG JASPER THERAPEUTICS, INC. AND THE INVESTORS SIGNATORY THERETO
2026-07-178-K10.1FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF JULY 16, 2026, BY AND AMONG JASPER THERAPEUTICS, INC. AND EACH INVESTOR LISTED ON EXHIBIT A THERETO
2025-02-2810-K10.17JASPER THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY.
2024-06-128-K10.6AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED AS OF JUNE 10, 2024, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND EDWIN TUCKER
2024-06-128-K10.5AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED AS OF JUNE 10, 2024, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND JEET MAHAL
2024-06-128-K10.4AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED AS OF JUNE 10, 2024, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND HERB CROSS
2024-06-128-K10.3AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED AS OF JUNE 10, 2024, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND RONALD MARTELL
2024-03-0510-K10.36OFFER LETTER, DATED SEPTEMBER 19, 2023, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND HERB CROSS
2024-03-0510-K10.35OFFER LETTER, DATED JUNE 7, 2023, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND EDWIN TUCKER
2023-08-1110-Q10.2AMENDMENT NO. 2 TO THE EXCLUSIVE LICENSE AGREEMENT, DATED JULY 27, 2023, BETWEEN STANFORD UNIVERSITY AND JASPER THERAPEUTICS, INC
2023-06-088-K10.1JASPER THERAPEUTICS, INC. AMENDED AND RESTATED 2022 INDUCEMENT EQUITY INCENTIVE PLAN
2023-04-148-K10.2FIRST AMENDMENT TO EMPLOYMENT AGREEMENT, DATED APRIL 13, 2023, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND RONALD MARTELL
2023-04-148-K10.1LETTER REGARDING SERVICE AGREEMENT, DATED APRIL 13, 2023, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND WILLIAM LIS
2023-03-0810-K10.17JASPER THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
2022-11-1010-Q10.1CONTROLLED EQUITY OFFERINGSM SALES AGREEMENT, DATED AS OF NOVEMBER 10, 2022, BY AND BETWEEN THE REGISTRANT AND CANTOR FITZGERALD & CO
2022-05-1210-Q10.6SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS, DATED MARCH 17, 2022, BY AND BETWEEN THE REGISTRANT AND KEVIN N. HELLER, M.D
2022-03-168-K10.1JASPER THERAPEUTICS, INC. 2022 INDUCEMENT EQUITY INCENTIVE PLAN
2022-03-118-K10.1SERVICE AGREEMENT, DATED MARCH 7, 2022, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND WILLIAM LIS
2022-02-288-K10.1EMPLOYMENT AGREEMENT, DATED FEBRUARY 25, 2022, BETWEEN JASPER THERAPEUTICS, INC. AND RONALD MARTELL
2021-10-298-K10.1JASPER THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
2021-09-298-K10.14AMENDMENT TO SPONSOR SUPPORT AGREEMENT, DATED AS OF SEPTEMBER 24, 2021, BY AND AMONG AMPLITUDE HEALTHCARE ACQUISITION CORPORATION, AMPLITUDE HEALTHCARE HOLDINGS LLC AND JASPER THERAPEUTICS, INC.
2021-09-298-K10.9EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 24, 2021, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND KEVIN HELLER
2021-09-298-K10.8EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 24, 2021, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND JEET MAHAL
2021-09-298-K10.7EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 24, 2021, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND WILLIAM LIS
2021-09-298-K10.6JASPER THERAPEUTICS, INC., 2021 EMPLOYEE STOCK PURCHASE PLAN
2021-09-298-K10.5JASPER THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN FORM OF RSU AWARD GRANT NOTICE AND AWARD AGREEMENT (RSU AWARD)
2021-09-298-K10.4JASPER THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN FORM OF STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT
2021-09-298-K10.3JASPER THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN
2021-09-298-K10.2AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 24, 2021, BY AND AMONG JASPER THERAPEUTICS, INC. AND THE STOCKHOLDERS PARTY THERETO
2021-05-068-K10.4FORM OF AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
2021-05-068-K10.3FORM OF JASPER THERAPEUTICS, INC. STOCKHOLDER SUPPORT AGREEMENT
2021-05-068-K10.2SPONSOR SUPPORT AGREEMENT, DATED AS OF MAY 6, 2021, BY AND AMONG AMPLITUDE HEALTHCARE ACQUISITION CORPORATION, AMPLITUDE HEALTHCARE HOLDINGS LLC AND JASPER THERAPEUTICS, INC
2021-05-068-K10.1FORM OF SUBSCRIPTION AGREEMENT
2020-01-088-K10.2LETTER AGREEMENT, DATED JANUARY 6, 2020, BY AND BETWEEN THE COMPANY AND VISHAL KAPOOR
2020-01-088-K10.1EMPLOYMENT AGREEMENT, DATED JANUARY 6, 2020, BY AND BETWEEN THE COMPANY AND VISHAL KAPOOR
2019-11-258-K10.4PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, DATED NOVEMBER 19, 2019, BY AND BETWEEN THE COMPANY AND THE SPONSOR.
2019-11-258-K10.3REGISTRATION RIGHTS AGREEMENT, DATED NOVEMBER 19, 2019, BY AND BETWEEN THE COMPANY AND THE SPONSOR.
2019-11-258-K10.2INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED NOVEMBER 19, 2019, BY AND BETWEEN THE COMPANY AND CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS TRUSTEE.
2019-11-258-K10.1LETTER AGREEMENT, DATED NOVEMBER 19, 2019, BY AND AMONG THE COMPANY, ITS OFFICERS, DIRECTORS AND THE SPONSOR.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
BioCardia, Inc. (BCDA)United States$0.016B
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
Pluri Inc. (PLUR)$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
CEL SCI CORP (CVM)United States$0.030B-0.81